SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
DATE OF REPORT - DECEMBER 13, 2002
(Date of earliest event reported)
ALKERMES, INC.
(Exact name of Registrant as specified in its charter)
PENNSYLVANIA 1-14131 23-2472830
(State of incorporation) (Commission file number) (IRS employer
identification number)
88 SIDNEY STREET, CAMBRIDGE, MASSACHUSETTS 02139
(Address of principal executive offices, zip code)
AREA CODE (617) 494-0171
(Telephone number)
ITEM 5. OTHER INFORMATION.
On December 13, 2002, Alkermes, Inc. and Eli Lilly and Company
announced amendments to their collaboration to develop inhaled formulations of
insulin based on Alkermes' AIR(R) pulmonary drug delivery technology and an
agreement pursuant to which Lilly will purchase $30 million of newly issued
convertible preferred stock of Alkermes. A copy of the press release issued
by Alkermes on December 13, 2002, is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits
3.1 Amendment to Third Amended and Restated Articles of
Incorporation, as filed with the Pennsylvania Secretary of
State on December 16, 2002 (2002 Preferred Stock Terms).
4.1 Specimen of 2002 Preferred Stock Certificate of Alkermes,
Inc.
4.2 Stock Purchase Agreement, dated as of December 13, 2002, by
and between Alkermes, Inc. and Eli Lilly and Company.
99.1 Press Release issued by Alkermes, Inc., dated December 13,
2002.
2
SIGNATURES
Pursuant to requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.
Dated: December 16, 2002 Alkermes, Inc.
By: /s/ James M. Frates
---------------------------------
James M. Frates
Vice President, Chief Financial
Officer, and Treasurer
3
ALKERMES, INC.
CURRENT REPORT ON FORM 8-K
EXHIBIT INDEX
EXHIBIT NO. EXHIBIT
---------- -------
3.1 Amendment to Third Amended and Restated Articles of
Incorporation, as filed with the Pennsylvania Secretary of State
on December 16, 2002 (2002 Preferred Stock Terms).
4.1 Specimen of 2002 Preferred Stock Certificate of Alkermes, Inc.
4.2 Stock Purchase Agreement, dated as of December 13, 2002, by and
between Alkermes, Inc. and Eli Lilly and Company.
99.1 Press Release issued by Alkermes, Inc., dated December 13, 2002.
4